Myopia Treatment

Low-dose atropine is a clinically proven medication that works at the biochemical level to slow myopia progression in children. Unlike other myopia management options, it doesn't involve wearing special lenses, making it ideal for young children.

Atropine drops are typically used once a day at bedtime. The medication works by temporarily blocking the eye's focusing mechanism and influencing biochemical changes in the eye that help slow its elongation (the main cause of myopia progression).
Clinical studies show that low-concentration Atropine (0.01% to 0.05%) can slow myopia progression in children by 30-50% with minimal side effects. The earlier treatment begins, the better the long-term results for your child's vision health.
The drops are painless but might cause a mild sensation of discomfort such as slight irritation or a dry feeling when first applied. This is typically brief and usually goes away quickly. Most children adapt to the drops within a few days of starting treatment.
The effect of low-dose Atropine may not be immediately noticeable, but it can take a few months of consistent use before you start to see measurable results in slowing the progression of myopia. Regular follow-up appointments will help track your child's progress.
Atropine therapy manages myopia but does not cure it. Glasses or contact lenses are still needed with the use of Atropine. The goal of treatment is to slow down the progression of myopia to prevent high myopia and reduce the risk of associated eye conditions later in life.
Low-dose Atropine is generally well tolerated, but some people may experience mild side effects, which include light sensitivity, difficulty with near vision, mild eye irritation, redness or dryness, and temporary blurry vision. These effects are typically minimal with the low concentrations used for myopia control.

Low-dose Atropine therapy has been shown to be safe and effective for children. In the concentrations used for myopia control (typically 0.01% to 0.05%), side effects are minimal. However, as with any medical treatment, it should be administered under the supervision of an eye care professional.
Atropine therapy for myopia control is typically a long-term treatment that continues throughout the years when myopia tends to progress most rapidly (usually until late teens). Your eye doctor will monitor your child's progress regularly and adjust the treatment plan as needed.
Yes, Atropine drops can be used in combination with other myopia management strategies such as orthokeratology (Ortho-K) lenses or MiSight contact lenses for enhanced effectiveness in some cases. Your eye doctor will recommend the best combination based on your child's specific needs.
Regular Atropine (1%) has been used for decades in eye care for pupil dilation and other purposes, but causes significant side effects like blurred near vision and light sensitivity. Low-dose Atropine (0.01% to 0.05%) used for myopia control provides the benefits of slowing myopia progression with minimal side effects.